Skip to main content

Advertisement

Log in

Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study

  • Original article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

The lack of high-quality clinical evidences hindered broad consensus on optimal therapies for primary nephrotic syndromes. The aim of the present study was to compare prevalence of immunosuppressive drug use in patients with primary nephrotic syndrome across 6 regions in Japan.

Methods

Between 2009 and 2010, 380 patients with primary nephrotic syndrome in 56 hospitals were enrolled in a prospective cohort study [Japan Nephrotic Syndrome Cohort Study (JNSCS)], including 141, 151, and 38 adult patients with minimal change disease (MCD), membranous nephropathy (MN), and focal segmental glomerulosclerosis (FSGS), respectively. Their clinical characteristics were compared with those of patients registered in a large nationwide registry of kidney biopsies [Japan Renal Biopsy Registry (J-RBR)]. The regional prevalence of use of each immunosuppressive drug was assessed among adult MCD, MN, and FSGS patients who underwent immunosuppressive therapy in the JNSCS (n = 139, 127, and 34, respectively). Predictors of its use were identified using multivariable-adjusted logistic regression models.

Results

The clinical characteristics of JNSCS patients were comparable to those of J-RBR patients, suggesting that the JNSCS included the representatives in the J-RBR. The secondary major immunosuppressive drugs were intravenous methylprednisolone [n = 33 (24.6%), 24 (19.7%), and 9 (28.1%) in MCD, MN, and FSGS, respectively] and cyclosporine [n = 25 (18.7%), 62 (50.8%), and 16 (50.0%), respectively]. The region was identified as a significant predictor of use of intravenous methylprednisolone in MCD and MN patients.

Conclusion

Use of intravenous methylprednisolone for MCD and MN differed geographically in Japan. Its efficacy should be further evaluated in a well-designed trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Hull RP, Goldsmith DJA. Nephrotic syndrome in adults. BMJ. 2008;336:1185–9.

    Article  Google Scholar 

  2. Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65:1400–7.

    Article  Google Scholar 

  3. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC. Toronto Glomerulonephritis Registry Group. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol. 2005; 16:1061–8.

    Article  Google Scholar 

  4. Kono M, Yasuda S, Kato M, Kanetsuka Y, Kurita T, Fujieda Y, et al. Long-term outcome in Japanese patients with lupus nephritis. Lupus. 2014;23:1124–32.

    Article  CAS  Google Scholar 

  5. Christiansen CF, Schmidt M, Lamberg AL, Horvath-Puho E, Baron JA, Jespersen B, et al. Kidney disease and risk of venous thromboembolism: a nationwide population-based case-control study. J Thromb Haemost. 2014;12:1449–54.

    Article  CAS  Google Scholar 

  6. Heaf J, Løkkegaard H, Larsen S. The epidemiology and prognosis of glomerulonephritis in Denmark 1985–1997. Nephrol Dial Transplant. 1999;14:1889–97.

    Article  CAS  Google Scholar 

  7. Wu HM, Tang JL, Cao L, Sha ZH, Li Y. Interventions for preventing infection in nephrotic syndrome. Cochrane Database Syst Rev. 2012;4:CD003964.

    Google Scholar 

  8. Soeiro EMD, Koch VH, Fujimura MD, Okay Y. Influence of nephrotic state on the infectious profile in childhood idiopathic nephrotic syndrome. Rev Hosp Clin Fac Med Sao Paulo. 2004;59:273–8.

    Article  Google Scholar 

  9. Christiansen CF, Onega T, Sværke C, Körmendiné Farkas D, Jespersen B, Baron JA, et al. Risk and prognosis of cancer in patients with nephrotic syndrome. Am J Med. 2014;127:871–7.e1.

    Article  Google Scholar 

  10. Ordoñez JD, Hiatt R, Killebrew EJ, Fireman BH. The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int. 1993;44:638–42.

    Article  Google Scholar 

  11. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, et al. Japan renal biopsy registry: The first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol. 2011;15:493–503.

    Article  Google Scholar 

  12. Covic A, Schiller A, Volovat C, Gluhovschi G, Gusbeth-Tatomir P, Petrica L, et al. Epidemiology of renal disease in Romania: a 10 year review of two regional renal biopsy databases. Nephrol Dial Transplant. 2006;21:419–24.

    Article  Google Scholar 

  13. Komatsuda A, Nakamoto Y, Imai H, Yasuda T, Yanagisawa MM, Wakui H, et al. Kidney diseases among the elderly–a clinicopathological analysis of 247 elderly patients. Intern Med. 1993;32:377–81.

    Article  CAS  Google Scholar 

  14. Gesualdo L, Di Palma AM, Morrone LF, Strippoli GF, Schena FP. Italian Immunopathology Group IS of N. The Italian experience of the national registry of renal biopsies. Kidney Int. 2004;66:890–4.

    Article  Google Scholar 

  15. Naumovic R, Pavlovic S, Stojkovic D, Basta-Jovanovic G, Nesic V. Renal biopsy registry from a single centre in Serbia: 20 Years of experience. Nephrol Dial Transpl. 2009;24:877–85.

    Article  Google Scholar 

  16. Polito MG, De Moura LAR, Kirsztajn GM. An overview on frequency of renal biopsy diagnosis in Brazil: Clinical and pathological patterns based on 9617 native kidney biopsies. Nephrol Dial Transpl. 2010;25:490–6.

    Article  Google Scholar 

  17. Rychlík I, Jancová E, Tesar V, Kolsky A, Lácha J, Stejskal J, et al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994–2000. Nephrol Dial Transpl. 2004;19:3040–9.

    Article  Google Scholar 

  18. Kidney Disease Improving Global Outcomes. KDIGO Clinical practice guideline for glomerulonephritis. Kidnet Int Suppl. 2012; 2:1–274.

    Article  Google Scholar 

  19. Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2014. Clin Exp Nephrol. 2016;20:342–70.

    Article  Google Scholar 

  20. Kaku Y, Ohtsuka Y, Komatsu Y, Ohta T, Nagai T, Kaito H, et al. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy. Clin Exp Nephrol. 2015;19:34–53.

    Article  Google Scholar 

  21. Ishikura K, Matsumoto S, Sako M, Tsuruga K, Nakanishi K, Kamei K, et al. Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy. Clin Exp Nephrol. 2015;19:6–33.

    Article  Google Scholar 

  22. Canetta PAA, Radhakrishnan J. The evidence-based approach to adult-onset idiopathic nephrotic syndrome. Front Pediatr. 2015;3:78.

    Article  Google Scholar 

  23. Barbour S, Beaulieu M, Gill J, Espino-Hernandez G, Reich HN, Levin A. The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: A survey of nephrologists. Clin Kidney J. 2014;7:538–45.

    Article  Google Scholar 

  24. Samuel S, Morgan CJ, Bitzan M, Mammen C, Dart AB, Manns BJ, et al. Substantial practice variation exists in the management of childhood nephrotic syndrome. Pediatr Nephrol. 2013;28:2289–98.

    Article  Google Scholar 

  25. Fernandez-Juarez G, Villacorta J, Ruiz-Roso G, Panizo N, Martinez-Marín I, Marco H, et al. Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis. Clin Kidney J. 2016;9:381–6.

    Article  CAS  Google Scholar 

  26. Yokoyama H, Taguchi T, Sugiyama H, Sato H. Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2012;16:557–63.

    Article  Google Scholar 

  27. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.

    Article  CAS  Google Scholar 

  28. Kidney Disease Improving Global Outcomes. KDIGO Clinical practice guideline for glomerulonephritis, Chap. 5: minimal-change disease in adults. Kidney Int Suppl. 2012; 2:177–80.

    Article  Google Scholar 

  29. Shinzawa M, Yamamoto R, Nagasawa Y, Oseto S, Mori D, Tomida K, et al. Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: A retrospective cohort study. Clin J Am Soc Nephrol. 2014;9:1040–8.

    Article  CAS  Google Scholar 

  30. Yeung CK, Wong KL, Ng WL. Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome. Aust N Z J Med. 1983;13:349–51.

    Article  CAS  Google Scholar 

  31. Imbasciati E, Gusmano R, Edefonti A, Zucchelli P, Pozzi C, Grassi C, et al. Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome. BMJ. 1985;291:1305–8.

    Article  CAS  Google Scholar 

  32. Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002;346:913–23.

    Article  CAS  Google Scholar 

  33. Fukudome K, Fujimoto S, Sato Y, Kitamura K. Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults. Nephrology. 2012;17:263–8.

    Article  CAS  Google Scholar 

  34. Ponticelli C, Zucchelli P, Imbasciati E, Cagnoli L, Pozzi C, Passerini P, et al. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 1984;310:946–50.

    Article  CAS  Google Scholar 

  35. Ponticelli C, Zucchelli P, Passerini P, Cagnoli L, Cesana B, Pozzi C, et al. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med. 1989;320:8–13.

    Article  CAS  Google Scholar 

  36. Ponticelli C, Zucchelli P, Passerini P, Cesana B. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med. 1992;327:599–603.

    Article  CAS  Google Scholar 

  37. Ponticelli C, Zucchelli P, Passerini P, Cesana B, Locatelli F, Pasquali S, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int. 1995;48:1600–4.

    Article  CAS  Google Scholar 

  38. Kidney Disease Improving Global Outcomes. KDIGO Clinical practice guideline for glomerulonephritis, Chap. 7: idiopathic membranous nephropathy. Kidney Int Suppl. 2012; 2:186–97.

    Article  Google Scholar 

  39. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int. 1995;47:1130–5.

    Article  CAS  Google Scholar 

  40. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int. 2001;59:1484–90.

    Article  CAS  Google Scholar 

  41. Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11–21.

    Article  CAS  Google Scholar 

  42. Akiyama S, Akiyama M, Imai E, Ozaki T, Matsuo S, Maruyama S. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol. 2015;19:653–60.

    Article  CAS  Google Scholar 

  43. Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RAK. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol. 2014;25:1357–66.

    Article  CAS  Google Scholar 

  44. Timmermans SAMEG., Abdul Hamid MA, Cohen Tervaert JW, Damoiseaux JGMC., Van Paassen P. Anti-PLA2R antibodies as a prognostic factor in PLA2R-related membranous nephropathy. Am J Nephrol. 2015;42:70–7.

    Article  CAS  Google Scholar 

  45. Wei SY, Wang YX, Li JS, Zhao SL, Diao TT, Waang Y, et al. Serum anti-PLA2R antibody predicts treatment outcome in idiopathic membranous nephropathy. Am J Nephrol. 2016;43:129–40.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by a Grant-in-Aid for intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants for the Ministry of Health, Labor, and Welfare of Japan. JNSCS has been supported by a large number of investigator in 56 participating facilities (now 55 facilities because of a consolidation of two facilities); Hokkaido University Hospital, Sapporo, Hokkaido (Saori Nishio, Yasunobu Ishikawa, Daigo Nakazawa, and Tasuku Nakagaki); JCHO Sendai Hospital, Sendai, Miyagi (Toshinobu Sato, Mitsuhiro Sato, and Satoru Sanada); Tohoku University Hospital, Sendai, Miyagai (Hiroshi Sato, Mariko Miyazaki, Takashi Nakamichi, Tae Yamamoto, Kaori Narumi, and Gen Yamada); Yamagata University Hospital, Yamagata, Yamagata (Tsuneo Konta, and Kazuobu Ichikawa); Fukushima Medical University Hospital, Fukushima, Fukushima (Junichiro James Kazama, Tsuyoshi Watanabe, Koichi Asahi, Yuki Kusano, and Kimio Watanabe); University of Tsukuba Hospital, Tsukuba, Ibaraki (Kunihiro Yamagata, Joichi Usui, Shuzo Kaneko, and Tetsuya Kawamura); Gunma University Hospital, Maeashi, Gunma (Keiju Hiromura, Akito Maeshima, Yoriaki Kaneko, Hidekazu Ikeuchi, Toru Sakairi, and Masao Nakasatomi); Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama (Hajime Hasegawa, Takatsugu Iwashita, Taisuke Shimizu, Koichi Kanozawa, Tomonari Ogawa, Kaori Takayanagi, and Tetsuya Mitarai); Department of Nephrology, Saitama Medical University, Irumagun, Saitama (Hirokazu Okada, Tsutomu Inoue, Hiromichi Suzuki, and Kouji Tomori); Tokyo Women’s Medical University, Shinjuku-ku, Tokyo (Kosaku Nitta, Takahito Moriyama, Akemi Ino, and Masayo Sato); Teikyo University School of Medicine, Itabashi-ku, Tokyo (Shunya Uchida, Hideaki Nakajima, Hitoshi Homma, Nichito Nagura, Yoshifuru Tamura, Shigeru Shibata, and Yoshihide Fujigaki); Juntendo Faculty of Medicine, Bunkyo-ku, Tokyo (Yusuke Suzuki, Yukihiko Takeda, Isao Osawa, and Teruo Hidaka); St. Marianna University, Kawasaki, Kanagawa (Yugo Shibagaki, Sayuri Shirai, Daisuke Ichikawa, Tsutomu Sakurada, Tomo Suzuki, and Mikako Hisamichi); Niigata University Medical and Dental Hospital, Niigata, Niigata (Ichiei Narita, Naohumi Imai, Yumi Ito, Shin Goto, Yoshikatsu Kaneko, and Rhohei Kaseda); Kanazawa Medical University, Uchinada, Ishikawa (Hitoshi Yokoyama, Keiji Fujimoto, and Norifumi Hayashi); Kanazawa Univeristy Hospital, Kanazawa, Ishikawa (Takashi Wada, Miho Shimizu, Kengo Furuichi, Norihiko Sakai, Yasunori Iwata, Tadashi Toyama, and Shinji Kitajima); National Hospital Organization Kanazawa Medical Center, Kanazawa, Ishikawa (Kiyoki Kitagawa); Ogaki Municipal Hospital, Ogaki, Gifu (Hiroshi Sobajima, Norimi Ohashi, So Oshitani, and Kiyohito Kawashima); Gifu Prefectural Tajimi Hospital, Tajimi, Gifu (Tetsushi Mimura); Hamamatsu University Hospital, Hamamatsu, Shizuoka (Hidemo Yasuda, Akira Hishida, and Yoshihide Fujigaki); Shizuoka General Hospital, Shizuoka, Shizuoka (Satoshi Tanaka, and Noriko Mori); Chutoen General Medical Center, Kakegawa, Shizuoka (Toshiyuki Akahori, and Yutaka Fujita); Nagoya University Graduate School of Medicine, Nagoya, Aichi (Shoichi Maruyama, Naotake Tsuboi, Tomoki Kosugi, Takuji Ishimoto, Takayuki Katsuno, Noritoshi Kato, and Waichi Sato); Japanese Red Cross Nagoya Daini Hospital, Nagoya, Aichi (Asami Takeda, Kunio Morozumi, Yasuhiro Ohtsuka, Hibiki Shinjo, and Akihito Tanaka); Fujita Health University School of Medicine, Toyoake, Aichi (Hiroki Hayashi, Yukio Yuzawa, Midori Hasegawa, Daijo Inaguma, Shigehisa Koide, and Kazuo Takahashi); Konan Kosei Hospital, Konan, Aichi (Takeyuki Hiramatsu, Shinji Furuta, and Hideaki Ishikawa); Anjo Kosei hospital, Anjo, Aichi (Hirofumi Tamai, and Takatoshi Morinaga); Ichinomiya Municipal Hospital, Ichinomiya, Aichi (Arimasa Shirasaki, Toshiki Kimura, and Mina Kato); Japanese Red Cross Nagoya Daiichi Hospital, Nagaoya, Aichi (Shizunori Ichida, and Nobuhide Endo); Kasugai Municipal Hospital, Kasugai, Aichi (Tomohiko Naruse, Yuzo Watanabe, and Yosuke Saka); Kainan hospital, Yatomi, Aichi (Satashi Suzuki, Michiko Yamazaki, and Rieko Morita); Masuko Memorial Hospital, Nagoya, Aichi (Kunio Morozumi, Kunio Morozumi, Kaoru Yasuda, Chika Kondo, Takahiro Morohiro, Rho Sato, and Yuichi Shirasawa); Chubu Rosai Hospital, Nagoya, Aichi (Yoshiro Fujita, Hideaki Shimizu, and Tatsuhito Tomino); Handa City Hospital, Handa, Aichi (Makoto Mizutani); Yokkaichi Municipal Hospital, Yokkaichi, Mie (Yosuke Saka, Hiroshi Nagaya, and Makoto Yamaguchi); Kitano Hospital, Osaka, Osaka (Tatsuo Tsukamoto, Eri Muso, Hiroyuki Suzuki, Tomomi Endo, and Hiroko Kakita); Toyonaka Municipal Hospital, Toyonaka, Osaka (Megumu Fukunaga); Osaka General Medical Center, Osaka, Osaka (Tatsuya Shoji, and Terumasa Hayashi); Osaka City University Hospital, Osaka, Osaka (Eiji Ishimura, Akihiro Tsuda, Shinya Nakatani, Ikue Kobayashi, Mitsuru Ichii, Akinobu Ochi, and Yoshiteru Ohno); Osaka Univeristy hospital, Suita, Osaka (Yoshitaka Isaka, Enyu Imai, Yasuyuki Nagasawa, Hirotsugu Iwatani, Ryohei Yamamoto, and Tomoko Namba); Kobe University hospital, Kobe, Hyogo (Shunsuke Goto MD, and Shinichi Nishi); Nara Medical University Hospital, Kashihara, Nara (Yasuhiro Akai, Ken-ichi Samejima, Masaru Matsui, Miho Tagawa, Kaori Tanabe, and Hideo Tsushima); Wakayama Medical University Hospital, Wakayama, Wakayama (Takashi Shigematsu MD, Masaki Ohya, Shigeo Negi, and Toru Mima); Shimane University Hospital, Izumo, Shimane (Takafumi Ito); Okayama Univeristy Hospital, Okayama, Okayama (Hitoshi Sugiyama, Keiko Tanaka, Toshio Yamanari, Masashi Kitagawa, Akifumi Onishi, and Koki Mise); Kawasaki Medical School, Kurashiki, Okayama (Naoki Kashihara, Tamaki Sasaki, Sohachi Fujimoto, and Hajime Nagasu); Graduate School of Medicine, The University of Tokushima,Tokushima,Tokushima (Kojiro Nagai, and Toshio Doi); Kagawa University, Miki-cho, Takamatsu, Japan (Tadashi Sofue, Hideyasu Kiyomoto, Kumiko Moriwaki, Taiga Hara, Yoko Nishijima, Yoshio Kushida, and Tetsuo Minamino); Kochi Medical School, Kochi University, Nankoku, Kochi (Terada Yoshio, Taro Horino, Yoshinori Taniguchi, Kosuke Inoue, Yoshiko Shimamura, and Tatsuki Matsumoto); Kyushu University Hospital, Fukuoka, Fukuoka (Kazuhiko Tsuruya, Hisako Yoshida, Naoki Haruyama, Shunsuke Yamada, Akihiro Tsuchimoto, and Yuta Matsukuma); Fukuoka University Hospital, Fukuoka, Fukuoka (Kosuke Masutani, Yasuhiro Abe, Aki Hamauchi, Tetsuhiko Yasuno, and Kenji Ito); Kurume University Hospital, Kurume, Fukuoka (Kei Fukami, Junko Yano, Chika Yoshida, Yuka Kurokawa, and Nao Nakamura); National Fukuoka Higashi Medical Center, Koga, Fukuoka (Ritsuko Katafuchi, Hiroshi Nagae, Shumei Matsueda, and Kazuto Abe); Nagasaki University Hospital, Nagasaki, Nagasaki (Tomoya Nishino, Tadashi Uramatsu, and Yoko Obata); Miyazaki University Hospital, Miyazaki, Miyazaki (Shouichi Fujimoto, Yuji Sato, Masao Kikuchi, Ryuzo Nishizono, Takashi Iwakiri, and Hiroyuki Komatsu). The register of patients with primary nephrotic syndrome in J-RBR between 2008 and 2011 was supported by many investigators in the following facilities: Asahikawa Medical University Hospital, Asahikawa, Hokkaido (Naoyuki Hasebe, Naoki Nakagawa, and Takayuki Okamoto); Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido (Saori Nishio); National Hospital Organization Hokkaido Medical Center, Sapporo, Hokkaido (Tomotsune Miyamoto and Masanori Ito); National Hospital Organization Hokkaido Medical Center, Sapporo, Hokkaido (Sekiya Shibazaki, Tomotsune Miyamoto, and Masanori Ito); Iwate Prefectural Central Hospital, Morioka, Iwate (Jun Soma, Izaya Nakaya, and Kazuhiro Yoshikawa); Yamagata University School of Medicine, Yamagata, Yamagata (Hiroshi Sato, Mariko Miyazaki, Takashi Nakamichi, Tae Yamamoto, Tsuneo Konta, and Kazunobu Ichikawa); Fukushima Medical University School of Medicine, Fukushima, Fukushima (Masaaki Nakayama, Koichi Asahi, and Hiroaki Satoh); Japan Community Health care Organization Sendai Hospital, Sendai, Miyagi (Toshinobu Sato, Asako Fujimori, Satoru Sanada, and Mitsuhiro Sato); Tohoku University Hospital and affiliated hospitals, Sendai, Miyagi (Hiroshi Sato, Mariko Miyazaki, Takashi Nakamichi, and Tae Yamamoto); Jichi Medical University, Shimotsuke, Tochigi (Daisuke Nagata, Shigeaki Muto, Osamu Saito, and Tetsu Akimoto); University of Tsukuba, Tsukuba, Ibaraki (Kunihiro Yamagata, Joichi Usui, and Tetsuya Kawamura); Mito Saiseikai General Hospital, Mito, Ibaraki (Itaru Ebihara and Chihiro Satho); Tokyo Medical University Ibaraki Medical Center, Inashiki, Ibaraki (Masaki Kobayashi, Kouichi Hirayama, and Homare Shimohata); Gunma University Graduate School of Medicine, Maebashi, Gunma (Keiju Hiromura, Yoriaki Kaneko, Hidekazu Ikeuchi, and Toru Sakairi); Saitama Medical University, Iruma, Saitama (Hirokazu Okada and Tsutomu Inoue); Saitama Medical University, Saitama Medical Center, Kwagoe, Saitama (Takatsugu Iwashita, Yuta Kogure, Kouichi Kanouzawa, and Hajime Hasegawa); National Hospital Organization Chiba-East Hospital (Hiroshi Kitamura, Toshiyuki Imazawa, Chieko Matsumura, and Naotake Akutsu, and Koichi Kamura); Showa University School of Medicine, Shinagawa-ku, Tokyo (Takanori Shibata); Tokyo Metropolitan Children’s Medical Center, Shinagawa-ku, Tokyo (Riku Hamada and Hiroshi Hataya); Nippon Medical School, Bunkyo-ku, Tokyo (Shuichi Tsuruoka, Yukinao Sakai, Akio Hirama, and Akiko Mii); Juntendo University Faculty of Medicine, Bunkyo-ku, Tokyo (Yusuke Suzuki, Miyuki Takagi, Hitoshi Suzuki, and Teruo Hidaka); Tokyo Women’s Medical University, Shinjuku-ku, Tokyo (Motoshi Hattori, Kenichiro Miura, Kiyonobu Ishizuka, Kosaku Nitta, Keiko Uchida, and Takahito Moriyama); Teikyo University School of Medicine, Itabashi-ku, Tokyo (Yoshihide Fujigaki); Nihon University School of Medicine, Itabashi-ku, Tokyo (Yoshinobu Fuke); The Jikei University School of Medicine, Minato-ku, Tokyo (Takashi Yokoo, Nobuo Tsuboi, and Kentaro Koike); The Jikei University School of Medicine, Daisan Hospital, Komae, Tokyo (Yoichi Miyazaki, Hiroyuki Ueda, Junichiro Kato, and Mai Tanaka); St. Marianna University School of Medicine, Kawasaki, Kanagawa (Tomo Suzuki, Daisuke Ichikawa, Sayuri Shirai, and Yugo Shibagaki); Yokohama City University Medical Center, Yokohama, Kanagawa (Nobuhito Hirawa, Sanae Saka, and Akira Fujiwara); Showa University Fujigaoka Hospital, Yokohama, Kanagawa (Yoshihiko Inoue); Niigata University Graduate School of Medical and Dental, NIigata, NIigata (Ichiei Narita, Shin Goto, Yumi Itoh, and Naofumi Imai); Toyama City Hospital, Toyama, Toyama (Satoshi Ota and Yoh-ichi Ishida); Toyama Prefectural Central Hospital, Toyama, Toyama (Masahiko Kawabata); Kanazawa Medical University School of Medicine, Kanazawa, Ishikawa (Hitoshi Yokoyama, Keiji Fujimoto, and Norifumi Hayashi); Pubulic Central Hospital of Matto-Ishikawa, Hakusan, Ishikawa (Kazuya Takasawa and Chikako Takaeda); National Hospital Organization Kanazawa Medical Center, Kanazawa, Ishikawa (Kiyoki Kitagawa); Kanazawa University Hospital, Kanazawa, Ishikawa (Takashi Wada, Kengo Furuichi, Miho Shimizu, and Norihiko Sakai); University of Fukui, Faculty of Medical Sciences, Yoshida, Fukui (Masayuki Iwano, Hideki Kimura, Naoki Takahashi, and Kenji Kasuno); Sugita Genpaku Memorial Obama Municipal Hospital, Obama, Fukui (Haruyoshi Yoshida and Takayasu Horiguchi); Shinshu University School of Medicine, Matsumoto, Nagano (Yuji Kamijo, Koji Hashimoto, Akinori Yamaguchi,, and Sonoda Kosuke); Fujinomiya City General Hospital, Fujinomiya, Shizuoka (Masanori Sakakima, Kazuto Kitajima, Taichi Sato, and Yutaro Kawakatsu); Hamamatsu University School of Medicine, University Hospital (Hideo Yasuda, Naro Ohashi, and Taichi Sato); Shizuoka General Hospital, Shizuoka, Shizuoka (Noriko Mori and Satoshi Tanaka); Japanese Red Cross Nagoya Daini Hospital, Nagoya, Aichi (Asami Takeda and Yasuhiro Otsuka); Nagoya University Graduate School of Medicine, Nagoya, Aichi (Seiichi Matsuo, Shoichi Maruyama, and Yoshinari Yasuda); Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi (Michio Fukuda, Masashi Mizuno, Taisei Suzuki, and Satoru Kominato); Aichi Children’s Health and Medical Center, Obu, Aichi (Naoya Fujita, Satoshi Hibino, and Kazuki Tanaka); Fujita Health University School of Medicine, Toyoake, Aichi (Yukio Yuzawa, Hiroki Hayashi, and Kazuo Takahashi); Aichi Medical University School of Medicine, Nagakute, Aichi (Yasuhiko Ito, Takuhito Nagai, Takayuki Katsuno, and Hironobu Nobata); Mie University Graduate School of Medicine, Tsu, Mie (Eiji Ishikawa, Mika Fujimoto, Tomohiro Murata, and Masaaki Ito); Kyoto Prefectural University of Medicine Graduate School of Medical Science, Kyoto, Kyoto (Keiichi Tamagaki, Tetsuro Kusaba, and Yayoi Shiotsu); Kyoto University Graduate School of Medicine, Kyoto, Kyoto (Motoko Yanagita, Hideki Yokoi, Kaoru Sakai, and Akira Ishii); Osaka University Graduate School of Medicine, Suita, Osaka (Yoshitaka Isaka, Ryohei Yamamoto, and Tomoko Namba); Osaka General Medical Center, Osaka, Osaka (Terumasa Hayashi and Tatsuya Shoji); Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Osaka (Tatsuo Tsukamoto, Tomomi Endo, and Eri Muso); Osaka Red Cross Hospital, Osaka, Osaka (Akira Sugawara, Masao Koshikawa, Yoshihisa Ogawa, and Tomoko Kawanishi); Osaka City General Hospital, Osaka, Osaka (Rika Fujimaru); Osaka City University Graduate School of Medicine (Eiji Ishimura, Katsuhito Mori, Akihiro Tsuda, and Shinya Nakatani); Ikeda City Hospital, Ikeda, Osaka (Nobuyuki Kajiwara); Toyonaka Municipal Hospital, Toyonaka, Osaka (Megumu Fukunaga); Kobe University Graduate School of Medicine, Kobe, Hyogo (Shinichi Nishi and Shunske Goto); Nara Medical University, Kashihara, Nara (Kazuhiko Tsuruya and Kenichi Samejima); Wakayama Medical University, Wakayama, Wakayama (Takashi Shigematsu, Masaki Ohya, and Yuko Shima); Shimane University Faculty of Medicine, Izumo, Shimane (Takafumi Ito); Tottori University Faculty of Medicine, Yonago, Tottori (Shinichi Okada, Koichi Kitamoto, Hiroki Yokoyama, and Yuko Yamada); Kawasaki Medical School, Kurashiki, Okayama (Naoki Kashihara, Tamaki Sasaki, and Hajime Nagasu); Okayama Saiseikai General Hospital, Okayama, Okayama (Makoto Hiramatsu, Keisuke Maruyama, and Noriya Momoki); Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Okayama (Hiroshi Morinaga, Keiko Tanaka, and Ayu Akiyama); Hiroshima University Hospital, Hiroshima, Hiroshiam (Takao Masaki, Shigehiro Doi, Ayumu Nakashima, and Toshiki Doi); Saiseikai Yamaguchi General Hospital, Yamaguchi, Yamaguchi (Tsuyoshi Imai); Tokushima University Graduate School, Tokushima, Tokushima (Shoji Kagami, Maki Urushihara, and Yukiko Kinoshita); Kagawa University Faculty of Medicine, Kita, Kagawa (Tetsuo Minamino, Tadashi Sofue, Yoko Nishijima, and Yoshio Kushida); Kochi University, Kochi Medical School, Nangoku, Kochi (Mikiya Fujieda and Masayuki Ishihara); Kurume University School of Medicine, Kurume, Fukuoka (Kei Fukami and Jyunko Yano); University of Occupational and Environmental Health, Kitakyushu, Fukuoka (Masahito Tamura and Tetsu Miyamoto); National Fukuoka Higashi Medical Center, Koga, Fukuoka (Ritsuko Katafuchi); Japanese Red Cross Fukuoka Hospital, Fukuoka, Fukuoka (Ken Hatae, Manao Nishimura, and Hiroyo Maruyama); Fukuoka University Faculty of Medicine, Fukuoka, Fukuoka (Hitoshi Nakashima and Kosuke Masutani); Kyushu University School of Medicine, Fukuoka, Fukuoka (Toshiaki Nakano, Akihiro Tsuchimoto, Shunsuke Yamada, and Yuta Matsukuma); Nagasaki University Hospital, Nagasaki, Nagasaki (Takashi Taguchi, Tomoya Nishino, Hideyuki Arai, Yoko Obata, and Tadashi Uramatsu); Kumamoto University Graduate School of Medical Sciences, Kumamoto, Kumamoto (Masashi Mukoyama and Masataka Adachi); University of Miyazaki Hospital, Miyazaki, Miyazaki (Shouichi Fujimoto, Yuji Sato, Masao Kikuchi, and Akihiro Minakawa).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshitaka Isaka.

Ethics declarations

Conflict of interest

The authors have declared that no conflict of interest exists.

Ethical approval

All procedures performed in J-RBR and JNSCS involving human participants were in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number 061171, 08212, and 13134 at the ethics committee of Osaka University Hospital) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in J-RBR and JNSCS.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 100 KB)

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamamoto, R., Imai, E., Maruyama, S. et al. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study. Clin Exp Nephrol 22, 1266–1280 (2018). https://doi.org/10.1007/s10157-018-1579-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-018-1579-x

Keywords

Navigation